טוען...
Polyclonal Anti-T-Cell Therapy for Type 1 Diabetes Mellitus of Recent Onset
The destruction of pancreatic β-cells in type 1 diabetes mellitus is mediated by autoreactive T-lymphocyte clones. We initiated a prospective randomized controlled trial of polyclonal rabbit anti-T-cell globulin (ATG) in patients with type 1 diabetes within 4 weeks of diagnosis and with residual pos...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SBDR - Society for Biomedical Diabetes Research
2004
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1783538/ https://ncbi.nlm.nih.gov/pubmed/17491669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2004.1.80 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|